Adenomatous Polyposis Coli Completed Phase 2 Trials for Sulindac (DB00605)

Also known as: Polyposis Coli / Familial Polyposis / Familial adenomatous polyposis

IndicationStatusPhase
DBCOND0031638 (Adenomatous Polyposis Coli)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01187901A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis PatientsPrevention